Patel Dinesh V Ph D - 15 Jan 2025 Form 4 Insider Report for Protagonist Therapeutics, Inc (PTGX)

Role
President and CEO, Director
Signature
/s/ Matthew Gosling, Attorney-in-Fact for Dinesh V. Patel, Ph.D.
Issuer symbol
PTGX
Transactions as of
15 Jan 2025
Transactions value $
$0
Form type
4
Date filed
17 Jan 2025, 17:46
Previous filing
06 Jan 2025
Next filing
20 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTGX Common Stock Tax liability $0 -12.6K -2.26% $0.00 546K 15 Jan 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units.